Organism ID | Organism Name | Taxonomy Level | Family | SuperKingdom | Isolation Part | Collection Location | Collection Time | Reference |
---|---|---|---|---|---|---|---|---|
NPO12714 | Dracaena cochinchinensis | Species | Asparagaceae | Eukaryota | Stems | Ningming County, Guangxi autonomous region, China | 2006-JAN |
PMID[17883259] |
NPO28024 | Rheum palmatum | Species | Polygonaceae | Eukaryota | TM-MC* | |||
NPO7632 | Rheum tanguticum | Species | Polygonaceae | Eukaryota | TM-MC* | |||
NPO88 | Rheum undulatum | Species | Polygonaceae | Eukaryota | Rhizomes |
PMID[10714491] |
||
NPO13545 | Danaus gilippus | Species | Nymphalidae | Eukaryota | UNPD* | |||
NPO15391 | Taraxacum kok-saghyz | Species | Asteraceae | Eukaryota | UNPD* | |||
NPO14554 | Stevia ovata | Species | Asteraceae | Eukaryota | UNPD* | |||
NPO13229 | Clibadium sprucei | Species | Asteraceae | Eukaryota | UNPD* | |||
NPO25238 | Rheum coreanum | Species | Polygonaceae | Eukaryota | TM-MC* | |||
NPO20881 | Rheum officinale | Species | Polygonaceae | Eukaryota | TM-MC* |
Target ID | Target Type | Target Name | Target Organism | Activity Type | Activity Relation | Value | Unit | Reference |
---|---|---|---|---|---|---|---|---|
NPT1 | Others | Radical scavenging activity | EC50 | = | 48.6 | 12749887 | ||
NPT32 | Organism | Mus musculus | Mus musculus | IC50 | > | 30000 | nM | 10714491 |
NPT32 | Organism | Mus musculus | Mus musculus | Inhibition | = | 13 | % | 10714491 |
NPT168 | Cell Line | P388 | Mus musculus | ED50 | = | 28.9 | ug/ml | 12036362 |
NPT1081 | Cell Line | BXPC-3 | Homo sapiens | GI50 | = | 6.3 | ug/ml | 12036362 |
NPT83 | Cell Line | MCF7 | Homo sapiens | GI50 | = | 3.4 | ug/ml | 12036362 |
NPT395 | Cell Line | SF-268 | Homo sapiens | GI50 | = | 3.1 | ug/ml | 12036362 |
NPT2 | Others | Unspecified | GI50 | = | 6.8 | ug/ml | 12036362 | |
NPT575 | Cell Line | KM-20L2 | Homo sapiens | GI50 | = | 3.8 | ug/ml | 12036362 |
NPT90 | Cell Line | DU-145 | Homo sapiens | GI50 | = | 2.7 | ug/ml | 12036362 |
NPT82 | Cell Line | MDA-MB-231 | Homo sapiens | IC50 | > | 50000 | nM | 16250636 |
NPT2 | Others | Unspecified | Activity | = | 2.49 | 17316918 | ||
NPT2 | Others | Unspecified | Activity | = | 87 | % | 17316918 | |
NPT2 | Others | Unspecified | Activity | = | 1.14 | nM | 17316918 | |
NPT451 | Organism | Helicobacter pylori | Helicobacter pylori | MIC | = | 264500 | nM | 17883259 |
NPT5816 | Individual Protein | Peroxisome proliferator-activated receptor alpha | Rattus norvegicus | Activity | > | 2 | 18272370 | |
NPT2 | Others | Unspecified | IC50 | = | 12.9 | ug | 9392877 | |
NPT2 | Others | Unspecified | IC50 | = | 119.14 | ug | 9392877 | |
NPT30 | Individual Protein | Cyclooxygenase-1 | Homo sapiens | IC50 | = | 25800 | nM | 18487053 |
NPT31 | Individual Protein | Cyclooxygenase-2 | Homo sapiens | IC50 | = | 19600 | nM | 18487053 |
NPT139 | Cell Line | HT-29 | Homo sapiens | IC50 | = | 24500 | nM | 20627379 |
NPT492 | Cell Line | Caco-2 | Homo sapiens | IC50 | > | 30000 | nM | 20627379 |
NPT483 | Individual Protein | Prelamin-A/C | Homo sapiens | Potency | = | 11220.2 | nM | PubChem BioAssay data set |
NPT48 | Individual Protein | Lysine-specific demethylase 4D-like | Homo sapiens | Potency | = | 22387.2 | nM | PubChem BioAssay data set |
NPT531 | Individual Protein | Nuclear receptor ROR-gamma | Mus musculus | Potency | = | 3548.1 | nM | PubChem BioAssay data set |
NPT1119 | Individual Protein | Arachidonate 12-lipoxygenase | Homo sapiens | Potency | = | 19952.6 | nM | PubChem BioAssay data set |
NPT2 | Others | Unspecified | Potency | = | 35481.3 | nM | PubChem BioAssay data set | |
NPT531 | Individual Protein | Nuclear receptor ROR-gamma | Mus musculus | Potency | = | 1412.5 | nM | PubChem BioAssay data set |
NPT2 | Others | Unspecified | IC50 | > | 25000 | nM | 21215623 | |
NPT365 | Individual Protein | NAD(P)H dehydrogenase [quinone] 1 | Mus musculus | Activity | > | 0.02 | nM | 21215623 |
NPT2 | Others | Unspecified | EC50 | = | 2400 | nM | 10.1007/s00044-009-9236-2 | |
NPT587 | Tissue | Liver microsome | Rattus norvegicus | EC50 | = | 661000 | nM | 10.1007/s00044-009-9236-2 |
NPT2 | Others | Unspecified | Potency | 4610.9 | nM | PubChem BioAssay data set | ||
NPT2 | Others | Unspecified | Potency | 2592.9 | nM | PubChem BioAssay data set | ||
NPT72 | Individual Protein | Solute carrier organic anion transporter family member 1B3 | Homo sapiens | Inhibition | = | 134.99 | % | 23571415 |
NPT73 | Individual Protein | Solute carrier organic anion transporter family member 1B1 | Homo sapiens | Inhibition | = | 300.18 | % | 23571415 |
NPT1604 | Individual Protein | Cytochrome P450 1B1 | Homo sapiens | IC50 | = | 800 | nM | 10.1039/C3MD00317E |
NPT1604 | Individual Protein | Cytochrome P450 1B1 | Homo sapiens | Ki | = | 2100 | nM | 10.1039/C0MD00242A |
NPT1603 | Individual Protein | Cytochrome P450 1A1 | Homo sapiens | Ki | = | 160 | nM | 10.1039/C0MD00242A |
NPT1173 | Organism | Candida albicans SC5314 | Candida albicans SC5314 | MIC95 | = | 150 | ug/ml | 25014026 |
NPT2580 | Organism | Candida dubliniensis | Candida dubliniensis | MIC95 | = | 150 | ug/ml | 25014026 |
NPT3676 | Organism | Candida famata | Candida famata | MIC95 | = | 18 | ug/ml | 25014026 |
NPT554 | Organism | Candida glabrata | Candida glabrata | MIC95 | = | 150 | ug/ml | 25014026 |
NPT2578 | Organism | Pichia guilliermondii | Meyerozyma guilliermondii | MIC95 | = | 150 | ug/ml | 25014026 |
NPT3678 | Organism | Candida inconspicua | Candida inconspicua | MIC95 | = | 300 | ug/ml | 25014026 |
NPT3153 | Organism | Kluyveromyces marxianus | Kluyveromyces marxianus | MIC95 | = | 150 | ug/ml | 25014026 |
NPT187 | Organism | Issatchenkia orientalis | Pichia kudriavzevii | MIC95 | = | 150 | ug/ml | 25014026 |
NPT820 | Organism | Clavispora lusitaniae | Clavispora lusitaniae | MIC95 | = | 300 | ug/ml | 25014026 |
NPT3677 | Organism | Pichia norvegensis | Pichia norvegensis | MIC95 | = | 75 | ug/ml | 25014026 |
NPT188 | Organism | Candida parapsilosis | Candida parapsilosis | MIC95 | = | 300 | ug/ml | 25014026 |
NPT186 | Organism | Candida tropicalis | Candida tropicalis | MIC95 | = | 300 | ug/ml | 25014026 |
Similarity level is defined by Tanimoto coefficient (Tc) between two molecules. Tc lies between [0, 1] where '1' indicates the highest similarity. What is Tanimoto coefficient
●  The left chart: Distribution of similarity level between NPC296920 and all remaining natural products in the NPASS database.
●  The right table: Most similar natural products (Tc>=0.56 or Top200).
Similarity Score | Similarity Level | Natural Product ID |
---|---|---|
1.0 | High Similarity | NPC90520 |
0.9904 | High Similarity | NPC280606 |
0.9717 | High Similarity | NPC180508 |
0.9717 | High Similarity | NPC228287 |
0.9712 | High Similarity | NPC94045 |
0.9537 | High Similarity | NPC141090 |
0.9537 | High Similarity | NPC203113 |
0.945 | High Similarity | NPC195466 |
0.945 | High Similarity | NPC474933 |
0.9352 | High Similarity | NPC276737 |
0.9352 | High Similarity | NPC22610 |
0.9327 | High Similarity | NPC164576 |
0.932 | High Similarity | NPC474603 |
0.932 | High Similarity | NPC12987 |
0.9279 | High Similarity | NPC226629 |
0.9266 | High Similarity | NPC808 |
0.9266 | High Similarity | NPC167934 |
0.9266 | High Similarity | NPC53906 |
0.9252 | High Similarity | NPC255068 |
0.9245 | High Similarity | NPC82016 |
0.9196 | High Similarity | NPC247364 |
0.9196 | High Similarity | NPC10932 |
0.9196 | High Similarity | NPC474565 |
0.9196 | High Similarity | NPC61516 |
0.9196 | High Similarity | NPC232084 |
0.9182 | High Similarity | NPC150624 |
0.9115 | High Similarity | NPC166759 |
0.9115 | High Similarity | NPC102639 |
0.9099 | High Similarity | NPC33270 |
0.9099 | High Similarity | NPC15860 |
0.9099 | High Similarity | NPC470759 |
0.9099 | High Similarity | NPC69261 |
0.9099 | High Similarity | NPC244816 |
0.9099 | High Similarity | NPC219070 |
0.9099 | High Similarity | NPC127894 |
0.9099 | High Similarity | NPC50521 |
0.9099 | High Similarity | NPC221549 |
0.9091 | High Similarity | NPC464 |
0.9091 | High Similarity | NPC185541 |
0.9057 | High Similarity | NPC35543 |
0.9035 | High Similarity | NPC476633 |
0.9029 | High Similarity | NPC161571 |
0.9029 | High Similarity | NPC275053 |
0.9029 | High Similarity | NPC248573 |
0.9018 | High Similarity | NPC190514 |
0.9009 | High Similarity | NPC85292 |
0.9009 | High Similarity | NPC54507 |
0.9009 | High Similarity | NPC114064 |
0.9009 | High Similarity | NPC229147 |
0.8981 | High Similarity | NPC168657 |
0.8972 | High Similarity | NPC245115 |
0.8972 | High Similarity | NPC75440 |
0.8957 | High Similarity | NPC473411 |
0.8957 | High Similarity | NPC262253 |
0.8957 | High Similarity | NPC71579 |
0.8957 | High Similarity | NPC41562 |
0.8938 | High Similarity | NPC184302 |
0.8929 | High Similarity | NPC259638 |
0.8879 | High Similarity | NPC282496 |
0.8879 | High Similarity | NPC233526 |
0.8879 | High Similarity | NPC228922 |
0.8879 | High Similarity | NPC84086 |
0.8879 | High Similarity | NPC136319 |
0.8879 | High Similarity | NPC197757 |
0.885 | High Similarity | NPC131118 |
0.8839 | High Similarity | NPC193067 |
0.8835 | High Similarity | NPC291789 |
0.8807 | High Similarity | NPC303521 |
0.8807 | High Similarity | NPC2682 |
0.8803 | High Similarity | NPC206487 |
0.8803 | High Similarity | NPC138248 |
0.8803 | High Similarity | NPC270030 |
0.8803 | High Similarity | NPC228503 |
0.8803 | High Similarity | NPC5796 |
0.8774 | High Similarity | NPC30506 |
0.8772 | High Similarity | NPC20674 |
0.8729 | High Similarity | NPC234400 |
0.8729 | High Similarity | NPC17943 |
0.8729 | High Similarity | NPC265483 |
0.8729 | High Similarity | NPC251855 |
0.8729 | High Similarity | NPC203133 |
0.8729 | High Similarity | NPC299584 |
0.8729 | High Similarity | NPC82483 |
0.8729 | High Similarity | NPC105718 |
0.8729 | High Similarity | NPC472093 |
0.8729 | High Similarity | NPC116907 |
0.8729 | High Similarity | NPC298757 |
0.8729 | High Similarity | NPC105031 |
0.8729 | High Similarity | NPC60885 |
0.8729 | High Similarity | NPC113495 |
0.8729 | High Similarity | NPC117214 |
0.8729 | High Similarity | NPC208950 |
0.8729 | High Similarity | NPC233410 |
0.8729 | High Similarity | NPC193544 |
0.8729 | High Similarity | NPC475169 |
0.8729 | High Similarity | NPC57490 |
0.8729 | High Similarity | NPC278955 |
0.8729 | High Similarity | NPC105925 |
0.8729 | High Similarity | NPC221077 |
0.8707 | High Similarity | NPC75713 |
0.8707 | High Similarity | NPC145780 |
0.8696 | High Similarity | NPC229401 |
0.8692 | High Similarity | NPC292452 |
0.8684 | High Similarity | NPC74821 |
0.8673 | High Similarity | NPC123948 |
0.8655 | High Similarity | NPC170485 |
0.8655 | High Similarity | NPC78974 |
0.8655 | High Similarity | NPC223136 |
0.8655 | High Similarity | NPC223953 |
0.8655 | High Similarity | NPC103823 |
0.8655 | High Similarity | NPC28730 |
0.8655 | High Similarity | NPC18924 |
0.8655 | High Similarity | NPC44748 |
0.8655 | High Similarity | NPC214406 |
0.8632 | High Similarity | NPC18128 |
0.8632 | High Similarity | NPC77789 |
0.8624 | High Similarity | NPC201959 |
0.8611 | High Similarity | NPC113457 |
0.8609 | High Similarity | NPC295259 |
0.8585 | High Similarity | NPC100340 |
0.8585 | High Similarity | NPC143659 |
0.8583 | High Similarity | NPC127587 |
0.8583 | High Similarity | NPC53781 |
0.8583 | High Similarity | NPC210355 |
0.8583 | High Similarity | NPC169474 |
0.8583 | High Similarity | NPC473221 |
0.8583 | High Similarity | NPC159968 |
0.8583 | High Similarity | NPC74817 |
0.8583 | High Similarity | NPC324112 |
0.8583 | High Similarity | NPC282000 |
0.8583 | High Similarity | NPC236791 |
0.8583 | High Similarity | NPC266555 |
0.8583 | High Similarity | NPC124452 |
0.8583 | High Similarity | NPC293054 |
0.8583 | High Similarity | NPC246620 |
0.8583 | High Similarity | NPC82679 |
0.8559 | High Similarity | NPC121115 |
0.8559 | High Similarity | NPC203924 |
0.8559 | High Similarity | NPC474160 |
0.8559 | High Similarity | NPC95168 |
0.8547 | High Similarity | NPC193364 |
0.8547 | High Similarity | NPC285289 |
0.8545 | High Similarity | NPC165386 |
0.8534 | High Similarity | NPC258979 |
0.8534 | High Similarity | NPC93398 |
0.8534 | High Similarity | NPC8283 |
0.8532 | High Similarity | NPC176527 |
0.8512 | High Similarity | NPC98631 |
0.8512 | High Similarity | NPC470213 |
0.8512 | High Similarity | NPC186843 |
0.8512 | High Similarity | NPC38017 |
0.8512 | High Similarity | NPC206615 |
0.8512 | High Similarity | NPC215300 |
0.8512 | High Similarity | NPC154866 |
0.8505 | High Similarity | NPC305205 |
0.85 | High Similarity | NPC76451 |
0.85 | High Similarity | NPC82299 |
0.8487 | Intermediate Similarity | NPC122792 |
0.8487 | Intermediate Similarity | NPC228972 |
0.8475 | Intermediate Similarity | NPC36016 |
0.8475 | Intermediate Similarity | NPC100099 |
0.8475 | Intermediate Similarity | NPC74137 |
0.8455 | Intermediate Similarity | NPC34864 |
0.8455 | Intermediate Similarity | NPC105727 |
0.8455 | Intermediate Similarity | NPC58427 |
0.8455 | Intermediate Similarity | NPC114392 |
0.8448 | Intermediate Similarity | NPC15805 |
0.8448 | Intermediate Similarity | NPC85895 |
0.8448 | Intermediate Similarity | NPC254625 |
0.8448 | Intermediate Similarity | NPC475961 |
0.8448 | Intermediate Similarity | NPC137294 |
0.8447 | Intermediate Similarity | NPC295295 |
0.8443 | Intermediate Similarity | NPC58164 |
0.8443 | Intermediate Similarity | NPC10225 |
0.8443 | Intermediate Similarity | NPC170844 |
0.8443 | Intermediate Similarity | NPC471519 |
0.8443 | Intermediate Similarity | NPC470633 |
0.8443 | Intermediate Similarity | NPC228769 |
0.8443 | Intermediate Similarity | NPC190144 |
0.8443 | Intermediate Similarity | NPC212015 |
0.8443 | Intermediate Similarity | NPC471518 |
0.8443 | Intermediate Similarity | NPC476968 |
0.843 | Intermediate Similarity | NPC46978 |
0.843 | Intermediate Similarity | NPC252131 |
0.8426 | Intermediate Similarity | NPC102216 |
0.8426 | Intermediate Similarity | NPC241891 |
0.8407 | Intermediate Similarity | NPC204120 |
0.8403 | Intermediate Similarity | NPC76465 |
0.8403 | Intermediate Similarity | NPC238810 |
0.8403 | Intermediate Similarity | NPC38761 |
0.8393 | Intermediate Similarity | NPC225679 |
0.8393 | Intermediate Similarity | NPC4493 |
0.8393 | Intermediate Similarity | NPC165770 |
0.8393 | Intermediate Similarity | NPC476632 |
0.839 | Intermediate Similarity | NPC212965 |
0.839 | Intermediate Similarity | NPC54972 |
0.839 | Intermediate Similarity | NPC49341 |
0.8378 | Intermediate Similarity | NPC202647 |
0.8378 | Intermediate Similarity | NPC36108 |
0.8378 | Intermediate Similarity | NPC233731 |
Similarity level is defined by Tanimoto coefficient (Tc) between two molecules.
●  The left chart: Distribution of similarity level between NPC296920 and all drugs/candidates.
●  The right table: Most similar clinical/approved drugs (Tc>=0.56 or Top200).
Similarity Score | Similarity Level | Drug ID | Developmental Stage |
---|---|---|---|
0.9029 | High Similarity | NPD1242 | Phase 1 |
0.8684 | High Similarity | NPD1548 | Phase 1 |
0.8547 | High Similarity | NPD1610 | Phase 2 |
0.8443 | Intermediate Similarity | NPD3027 | Phase 3 |
0.825 | Intermediate Similarity | NPD2982 | Phase 2 |
0.825 | Intermediate Similarity | NPD2983 | Phase 2 |
0.823 | Intermediate Similarity | NPD228 | Approved |
0.8211 | Intermediate Similarity | NPD1529 | Clinical (unspecified phase) |
0.8211 | Intermediate Similarity | NPD4908 | Phase 1 |
0.8167 | Intermediate Similarity | NPD2981 | Phase 2 |
0.813 | Intermediate Similarity | NPD1530 | Clinical (unspecified phase) |
0.8108 | Intermediate Similarity | NPD968 | Approved |
0.8095 | Intermediate Similarity | NPD1612 | Clinical (unspecified phase) |
0.8095 | Intermediate Similarity | NPD1613 | Approved |
0.8083 | Intermediate Similarity | NPD422 | Phase 1 |
0.808 | Intermediate Similarity | NPD4907 | Clinical (unspecified phase) |
0.8073 | Intermediate Similarity | NPD846 | Approved |
0.8073 | Intermediate Similarity | NPD940 | Approved |
0.8 | Intermediate Similarity | NPD4625 | Phase 3 |
0.7984 | Intermediate Similarity | NPD3018 | Phase 2 |
0.7951 | Intermediate Similarity | NPD4749 | Approved |
0.785 | Intermediate Similarity | NPD2934 | Approved |
0.785 | Intermediate Similarity | NPD2933 | Approved |
0.7812 | Intermediate Similarity | NPD1240 | Approved |
0.7805 | Intermediate Similarity | NPD3600 | Clinical (unspecified phase) |
0.7805 | Intermediate Similarity | NPD4379 | Clinical (unspecified phase) |
0.7778 | Intermediate Similarity | NPD2860 | Approved |
0.7778 | Intermediate Similarity | NPD5283 | Phase 1 |
0.7778 | Intermediate Similarity | NPD2859 | Approved |
0.776 | Intermediate Similarity | NPD6917 | Clinical (unspecified phase) |
0.7739 | Intermediate Similarity | NPD4750 | Phase 3 |
0.7727 | Intermediate Similarity | NPD3020 | Approved |
0.7698 | Intermediate Similarity | NPD2861 | Phase 2 |
0.7692 | Intermediate Similarity | NPD1607 | Approved |
0.767 | Intermediate Similarity | NPD111 | Approved |
0.7656 | Intermediate Similarity | NPD6410 | Clinical (unspecified phase) |
0.7656 | Intermediate Similarity | NPD6859 | Clinical (unspecified phase) |
0.7647 | Intermediate Similarity | NPD6671 | Approved |
0.7619 | Intermediate Similarity | NPD6584 | Phase 3 |
0.7586 | Intermediate Similarity | NPD5451 | Approved |
0.7576 | Intermediate Similarity | NPD1510 | Phase 2 |
0.7565 | Intermediate Similarity | NPD290 | Approved |
0.7547 | Intermediate Similarity | NPD9295 | Approved |
0.7541 | Intermediate Similarity | NPD1357 | Approved |
0.7521 | Intermediate Similarity | NPD5536 | Phase 2 |
0.75 | Intermediate Similarity | NPD2684 | Approved |
0.75 | Intermediate Similarity | NPD709 | Approved |
0.746 | Intermediate Similarity | NPD1283 | Approved |
0.7459 | Intermediate Similarity | NPD1182 | Approved |
0.744 | Intermediate Similarity | NPD1608 | Approved |
0.7436 | Intermediate Similarity | NPD3021 | Approved |
0.7436 | Intermediate Similarity | NPD3022 | Approved |
0.7407 | Intermediate Similarity | NPD970 | Clinical (unspecified phase) |
0.7405 | Intermediate Similarity | NPD2238 | Phase 2 |
0.7405 | Intermediate Similarity | NPD1558 | Phase 1 |
0.7398 | Intermediate Similarity | NPD1651 | Approved |
0.7395 | Intermediate Similarity | NPD821 | Approved |
0.7391 | Intermediate Similarity | NPD4357 | Discontinued |
0.7381 | Intermediate Similarity | NPD6582 | Phase 2 |
0.7381 | Intermediate Similarity | NPD1669 | Approved |
0.7381 | Intermediate Similarity | NPD6583 | Phase 3 |
0.7379 | Intermediate Similarity | NPD9089 | Approved |
0.7364 | Intermediate Similarity | NPD1432 | Clinical (unspecified phase) |
0.7339 | Intermediate Similarity | NPD2668 | Approved |
0.7339 | Intermediate Similarity | NPD2667 | Approved |
0.7339 | Intermediate Similarity | NPD4626 | Approved |
0.7333 | Intermediate Similarity | NPD1550 | Clinical (unspecified phase) |
0.7333 | Intermediate Similarity | NPD3540 | Phase 1 |
0.7333 | Intermediate Similarity | NPD1552 | Clinical (unspecified phase) |
0.7328 | Intermediate Similarity | NPD3134 | Approved |
0.7302 | Intermediate Similarity | NPD2232 | Approved |
0.7302 | Intermediate Similarity | NPD2233 | Approved |
0.7302 | Intermediate Similarity | NPD2230 | Approved |
0.7297 | Intermediate Similarity | NPD844 | Approved |
0.7282 | Intermediate Similarity | NPD9093 | Approved |
0.728 | Intermediate Similarity | NPD3847 | Discontinued |
0.7279 | Intermediate Similarity | NPD1549 | Phase 2 |
0.7273 | Intermediate Similarity | NPD4060 | Phase 1 |
0.7266 | Intermediate Similarity | NPD1511 | Approved |
0.7265 | Intermediate Similarity | NPD1358 | Approved |
0.7259 | Intermediate Similarity | NPD3539 | Phase 1 |
0.7259 | Intermediate Similarity | NPD6099 | Approved |
0.7259 | Intermediate Similarity | NPD6100 | Approved |
0.7259 | Intermediate Similarity | NPD2935 | Discontinued |
0.7259 | Intermediate Similarity | NPD1551 | Phase 2 |
0.725 | Intermediate Similarity | NPD5535 | Approved |
0.725 | Intermediate Similarity | NPD7843 | Approved |
0.7232 | Intermediate Similarity | NPD288 | Approved |
0.7222 | Intermediate Similarity | NPD1535 | Discovery |
0.7222 | Intermediate Similarity | NPD1281 | Approved |
0.7222 | Intermediate Similarity | NPD1091 | Approved |
0.7214 | Intermediate Similarity | NPD4378 | Clinical (unspecified phase) |
0.7214 | Intermediate Similarity | NPD7447 | Phase 1 |
0.7213 | Intermediate Similarity | NPD7157 | Approved |
0.7209 | Intermediate Similarity | NPD4624 | Approved |
0.7207 | Intermediate Similarity | NPD9296 | Approved |
0.72 | Intermediate Similarity | NPD1778 | Approved |
0.72 | Intermediate Similarity | NPD17 | Approved |
0.7193 | Intermediate Similarity | NPD289 | Clinical (unspecified phase) |
0.7177 | Intermediate Similarity | NPD1894 | Discontinued |
0.7174 | Intermediate Similarity | NPD3750 | Approved |
0.7165 | Intermediate Similarity | NPD1481 | Phase 2 |
0.7165 | Intermediate Similarity | NPD2231 | Phase 2 |
0.7165 | Intermediate Similarity | NPD1840 | Phase 2 |
0.7165 | Intermediate Similarity | NPD2235 | Phase 2 |
0.7164 | Intermediate Similarity | NPD4097 | Suspended |
0.7163 | Intermediate Similarity | NPD1512 | Approved |
0.7154 | Intermediate Similarity | NPD9494 | Approved |
0.7143 | Intermediate Similarity | NPD7212 | Phase 2 |
0.7143 | Intermediate Similarity | NPD7213 | Phase 3 |
0.712 | Intermediate Similarity | NPD5585 | Approved |
0.7103 | Intermediate Similarity | NPD1934 | Approved |
0.7101 | Intermediate Similarity | NPD3060 | Approved |
0.709 | Intermediate Similarity | NPD230 | Phase 1 |
0.7083 | Intermediate Similarity | NPD4675 | Approved |
0.7083 | Intermediate Similarity | NPD4678 | Approved |
0.7063 | Intermediate Similarity | NPD5846 | Approved |
0.7063 | Intermediate Similarity | NPD2423 | Clinical (unspecified phase) |
0.7063 | Intermediate Similarity | NPD6516 | Phase 2 |
0.7055 | Intermediate Similarity | NPD2393 | Clinical (unspecified phase) |
0.7055 | Intermediate Similarity | NPD2801 | Approved |
0.7054 | Intermediate Similarity | NPD3225 | Approved |
0.705 | Intermediate Similarity | NPD3892 | Phase 2 |
0.7049 | Intermediate Similarity | NPD1241 | Discontinued |
0.7045 | Intermediate Similarity | NPD7095 | Approved |
0.704 | Intermediate Similarity | NPD9545 | Approved |
0.7037 | Intermediate Similarity | NPD3052 | Approved |
0.7037 | Intermediate Similarity | NPD2568 | Approved |
0.7037 | Intermediate Similarity | NPD3054 | Approved |
0.7016 | Intermediate Similarity | NPD3596 | Phase 2 |
0.7015 | Intermediate Similarity | NPD3619 | Clinical (unspecified phase) |
0.7015 | Intermediate Similarity | NPD3620 | Phase 2 |
0.7008 | Intermediate Similarity | NPD3496 | Discontinued |
0.7007 | Intermediate Similarity | NPD2796 | Approved |
0.7 | Intermediate Similarity | NPD1203 | Approved |
0.7 | Intermediate Similarity | NPD2219 | Phase 1 |
0.7 | Intermediate Similarity | NPD2797 | Approved |
0.7 | Intermediate Similarity | NPD5307 | Clinical (unspecified phase) |
0.6992 | Remote Similarity | NPD3145 | Approved |
0.6992 | Remote Similarity | NPD3144 | Approved |
0.6985 | Remote Similarity | NPD4538 | Approved |
0.6985 | Remote Similarity | NPD4537 | Clinical (unspecified phase) |
0.6985 | Remote Similarity | NPD4536 | Approved |
0.6984 | Remote Similarity | NPD5691 | Approved |
0.6978 | Remote Similarity | NPD5698 | Clinical (unspecified phase) |
0.6977 | Remote Similarity | NPD5327 | Phase 3 |
0.6972 | Remote Similarity | NPD9094 | Approved |
0.697 | Remote Similarity | NPD600 | Approved |
0.697 | Remote Similarity | NPD596 | Approved |
0.697 | Remote Similarity | NPD1008 | Clinical (unspecified phase) |
0.6963 | Remote Similarity | NPD5735 | Approved |
0.6963 | Remote Similarity | NPD5124 | Phase 1 |
0.6963 | Remote Similarity | NPD5123 | Clinical (unspecified phase) |
0.6959 | Remote Similarity | NPD3882 | Suspended |
0.6953 | Remote Similarity | NPD3705 | Approved |
0.695 | Remote Similarity | NPD7124 | Phase 2 |
0.6944 | Remote Similarity | NPD1653 | Approved |
0.694 | Remote Similarity | NPD2674 | Phase 3 |
0.6937 | Remote Similarity | NPD9365 | Approved |
0.6929 | Remote Similarity | NPD1878 | Clinical (unspecified phase) |
0.6929 | Remote Similarity | NPD6398 | Clinical (unspecified phase) |
0.6923 | Remote Similarity | NPD6696 | Suspended |
0.6912 | Remote Similarity | NPD1772 | Clinical (unspecified phase) |
0.6905 | Remote Similarity | NPD6580 | Approved |
0.6905 | Remote Similarity | NPD6581 | Approved |
0.6905 | Remote Similarity | NPD3091 | Approved |
0.6897 | Remote Similarity | NPD3028 | Approved |
0.6897 | Remote Similarity | NPD4005 | Discontinued |
0.6894 | Remote Similarity | NPD4993 | Discontinued |
0.6889 | Remote Similarity | NPD943 | Approved |
0.6889 | Remote Similarity | NPD4140 | Approved |
0.688 | Remote Similarity | NPD9493 | Approved |
0.6871 | Remote Similarity | NPD37 | Approved |
0.6861 | Remote Similarity | NPD6111 | Discontinued |
0.686 | Remote Similarity | NPD1792 | Phase 2 |
0.686 | Remote Similarity | NPD9380 | Clinical (unspecified phase) |
0.6857 | Remote Similarity | NPD1652 | Phase 2 |
0.6853 | Remote Similarity | NPD7410 | Clinical (unspecified phase) |
0.685 | Remote Similarity | NPD6830 | Clinical (unspecified phase) |
0.6849 | Remote Similarity | NPD4380 | Phase 2 |
0.6846 | Remote Similarity | NPD4359 | Approved |
0.6846 | Remote Similarity | NPD3676 | Clinical (unspecified phase) |
0.6842 | Remote Similarity | NPD5752 | Clinical (unspecified phase) |
0.6842 | Remote Similarity | NPD1809 | Phase 2 |
0.6838 | Remote Similarity | NPD291 | Approved |
0.6833 | Remote Similarity | NPD2342 | Discontinued |
0.6829 | Remote Similarity | NPD7635 | Approved |
0.6824 | Remote Similarity | NPD7819 | Suspended |
0.6822 | Remote Similarity | NPD3092 | Approved |
0.6822 | Remote Similarity | NPD1611 | Approved |
0.6818 | Remote Similarity | NPD3690 | Phase 2 |
0.6818 | Remote Similarity | NPD3691 | Phase 2 |
0.6815 | Remote Similarity | NPD839 | Approved |
0.6815 | Remote Similarity | NPD6233 | Phase 2 |
0.6815 | Remote Similarity | NPD840 | Approved |
0.6814 | Remote Similarity | NPD845 | Approved |
0.6812 | Remote Similarity | NPD5588 | Approved |
0.6812 | Remote Similarity | NPD4108 | Discontinued |
0.6812 | Remote Similarity | NPD3748 | Approved |
0.6812 | Remote Similarity | NPD5960 | Phase 3 |
PubChem CID   | 6255462 |
ChEMBL   | CHEMBL291501 |
ZINC   |
Molecular Weight:   | 242.09 |
ALogP:   | -0.5046 |
MLogP:   | 2.78 |
XLogP:   | 3.955 |
# Rotatable Bonds:   | 6 |
Polar Surface Area:   | 49.69 |
# H-Bond Aceptor:   | 0 |
# H-Bond Donor:   | 2 |
# Rings:   | 2 |
# Heavy Atoms:   | 18 |